Yearly Archives: 2007

Uncategorized

Profiting from Social Networks and Idle Browsers

Came across an interesting article in BusinessWeek:“Here are two potentially billion-dollar questions: How can you turn the Web’s social-network users into consumers? And how can you turn idle browsing into a flourishing bottom line? Back in May, marketers hoped they might have the answer when social-networking giant Facebook opened its network to external developers. This [...]

Uncategorized

Treasure Ship’s Half-billion-dollar Question: Who Owns the Treasure?

Treasure ship’s half-billion-dollar question: Who owns it? The Merchant Royal limped through the sea on Sept. 23, 1641, weighed down by tons of gold, silver and jewels, and sank. The ship, though privately owned by Britons, carried a load of treasure fresh from Spain’s American mines. In May 2007, Tampa-based Odyssey Marine Exploration released footage [...]

Uncategorized

Taking Care of Web Site Performance Critical to E-business

Taking Care of Web Site Performance Critical to E-business While enormous amounts of money are spent on making a site look good and one more tranche of enormous sum of money on tech gizmos on the site, how much money is spent on monitoring and ensuring that your web site performs well at a basic [...]

atherosclerosis

SOD supplement may protect against atherosclerosis

SOD supplement may protect against atherosclerosis By staff reporter, 3/14/2007 A superoxide dismutase (SOD) supplement, GliSODin, in combination with diet and lifestyle changes can significantly reduce the risk of cardiovascular disease, French researchers have reported. SOD has a different mode of action to vitamins. First discovered in 1968, it is the first antioxidant mobilized by [...]

atherosclerosis

Isis cholesterol drug lowers LDL levels

Isis cholesterol drug lowers LDL levels 26th March 2007, By Victoria Harrison Isis Pharmaceuticals has said new results from its monotherapy phase II clinical trial of cholesterol drug showed improvements in LDL cholesterol. Patients with high cholesterol were treated for ten weeks with 400 mg/week of the drug ISIS 301012. In this study, increasing the [...]

heart-disease

Hemochromatosis gene linked to stroke risk

Hemochromatosis gene linked to stroke risk Mar 26, 2007 NEW YORK (Reuters Health) – Patients with a specific gene variation for hereditary hemochromatosis, an autosomal recessive disease associated with increased iron accumulation, have more than double the risk of stroke, new research suggests. Hemochromatosis affects how the body metabolizes iron, which results an iron build-up [...]

atherosclerosis

Experimental Heart Drug Fails to Slow Atherosclerosis

Cholesterol News: Experimental Heart Drug Fails to Slow Atherosclerosis By Marcia Trahan, March 26, 2007 Three new studies found that torcetrapib, an experimental heart drug, did not inhibit atherosclerosis, or plaque build-up in coronary arteries. Two studies’ results were presented March 26 at the American College of Cardiology’s annual meeting in New Orleans. A third [...]

atherosclerosis

Pfizer says new studies show higher dose of Lipitor slows atherosclerosis

Pfizer says new studies show higher dose of Lipitor slows atherosclerosis 26 Mar 2007 LONDON (AFX) – Pfizer Inc said results from two new imaging trials show a higher dose of its cholesterol-fighting drug Lipitor stopped the progression of atherosclerosis in patients with coronary heart disease or familial hypercholesterolemia (FH). The results are part of [...]

atherosclerosis

ACC: Atherosclerosis Impervious to HDL Infusions

ACC: Atherosclerosis Impervious to HDL Infusions By Crystal Phend, Staff Writer, MedPage Today March 26, 2007 NEW ORLEANS, March 26 — Artificially boosting high-density lipoprotein (HDL) levels does not reverse atherosclerosis, though it may have some vascular benefit, said researchers here. In the ERASE trial of 183 patients with recent acute coronary syndromes, weekly infusions [...]

atherosclerosis

Crestor Effective at Halting Early Atherosclerosis

Crestor Effective at Halting Early Atherosclerosis This press release issued by Eurekalert says that an international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis. Results from the study were reported at the annual meeting of [...]